Maletta Matthew Joseph

Avg. Two Year Performance

(82%) Avg. Purchase Return
(35%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(7%)(26%)(51%)(17%)(82%)
Purchase Success Rate2 of 30 of 30 of 31 of 30 of 3
Average Sale Return----------
Sale Success Rate----------
Drugs » Drug Manufacturers - Other

EVP, CLO & Company Secretary:

Holdings: 768.47K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--